Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocious puberty in children; NASCOBAL nasal spray to treat vitamin B12 deficiency; AVEED to treat hypogonadism; QWO, an injectable treatment for moderate to severe cellulite in the buttocks of adult women; PERCOCET to treat moderate-to-moderately-severe pain; TESTOPEL an implantable pellet indicated for TRT in conditions associated with a deficiency or absence of endogenous testosterone; EDEX to treat erectile dysfunction; LIDODERM a topical patch product containing lidocaine for the relief of pain; and products for the pain management and urology. The company's Sterile Injectables segment manufactures VASOSTRICT, a vasopressin injection; ADRENALIN, a non-selective adrenergic agonist; and APLISOL, which is a sterile aqueous solution, as well as generic sterile injectable products, including ertapenem for injections and ephedrine sulfate injections. Its Generic Pharmaceuticals segment offers solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmic products, and sprays. The company's International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas comprising attention deficit hyperactivity disorder, pain, women's health, oncology, and transplantation. The company sells its branded pharmaceuticals and generics to specialty physicians, retailers, clinics, government agencies, doctors, retail and specialty pharmacies, and specialty distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland. On August 16, 2022, Endo International plc, along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of New York.
Show more...
CEO
Blaise Coleman
Çalışanlar
2931
Ülke
IE
ISIN
IE00BJ3V9050
WKN
000A1XE6M
Kotasyonlar
0 Comments
Düşüncelerini paylaş
FAQ
Endo International hissesinin bugünkü fiyatı nedir?▼
ENDPQ’un güncel fiyatı $0 USD — son 24 saatte %+0% arttı. Endo International hissesinin fiyat performansını grafikte daha yakından izle.
Endo International hissesinin sembolü nedir?▼
Borsaya bağlı olarak hisse sembolü değişebilir. Örneğin, borsasında Endo International hisseleri ENDPQ sembolüyle işlem görür.
Endo International’in geçen yılki geliri ne kadardı?▼
Endo International’in geçen yılki geliri 2.01B USD tutarındadır.
Endo International’in geçen yılki net geliri neydi?▼
ENDPQ’in geçen yılki net geliri -2.45B USD.
Endo International’in kaç çalışanı var?▼
Nisan 01, 2026 itibarıyla şirketin 2,931 çalışanı bulunmaktadır.
Endo International hangi sektörde yer alıyor?▼
Endo International, Professional, Scientific, and Technical Services sektöründe faaliyet göstermektedir.
Endo International hisse bölünmesini ne zaman tamamladı?▼
Endo International son zamanlarda herhangi bir split gerçekleştirmedi.